Literature DB >> 3238767

Observations on antibody levels associated with active and passive immunity to African horse sickness.

N K Blackburn1, R Swanepoel.   

Abstract

Tests for neutralising (NT) antibodies to the nine serotypes of African horse sickness (AHS) virus on the sera of three groups of horses confirmed that an increasing number of immunisations with vaccine containing attenuated strains of serotypes 1 to 6 of the virus, leads to broader response to the various serotypes and to higher individual titres. Nevertheless some horses failed to respond to one or more serotypes despite receiving numerous immunisations and it was clear that vaccine containing only serotypes 1 to 6 could not be relied upon to induce adequate cross-immunity to serotypes 7 to 9 of the virus. Highest antibody titres and broadest cross-reactivity were recorded in a fourth group of horses which had apparently suffered natural infection recently. The levels of antibody acquired from colostrum by seven foals generally correlated well with the levels of antibody in the sera of their dams and the rate of decline of passively acquired antibody was proportional to initial titre. Antibodies to individual serotypes of virus declined to undetectable levels in two to four months from birth in some instances implying that susceptibility to infection could occur well before the age of six to nine months which is commonly recommended for initial immunisation. Vaccination of eight foals at three to four months of age resulted in weak antibody response but did not adversely affect pre-existing low levels of maternal antibody so that early immunisation could be recommended as a means for attempting to control the losses of foals experienced in Zimbabwe.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3238767     DOI: 10.1007/bf02239981

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  2 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

2.  African horse sickness in Zimbabwe: 1972 to 1981.

Authors:  N K Blackburn; R Swanepoel
Journal:  Trop Anim Health Prod       Date:  1988-08       Impact factor: 1.559

  2 in total
  1 in total

1.  Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.

Authors:  Eva Calvo-Pinilla; Francisco de la Poza; Simon Gubbins; Peter Paul Clement Mertens; Javier Ortego; Javier Castillo-Olivares
Journal:  Antiviral Res       Date:  2015-01-30       Impact factor: 5.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.